BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, ...

Orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water ...

India’s Venus Remedies has secured Qualified Infectious Disease Product designation from the United States Food and Drug ...

Florida biopharma Ligand Pharmaceuticals subsidiary Pelthos Therapeutics is to merge with Channel Therapeutics (NYSE American ...

Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

US cancer drug developer Werewolf Therapeutics today announced the appointment of Steven Bloom as chief business officer ...

Indian drugmaker Biocon (BSE: 532523) subsidiary Biocon Biologics has announced a settlement and license agreement with the ...

Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) announced that results from the Phase III clinical trial (NIHONBASHI ...

US gene therapy company bluebird bio (Nasdaq: BLUE) announced that after three weeks of engagement, including a timeline ...

US biopharma company Galmed Pharmaceuticals has entered into a research collaboration with Virginia Commonwealth University to investigate its lead candidate Aramchol (arachidyl amido cholanoic acid) ...